Munich - Delayed Quote EUR
Corcept Therapeutics Inc (HTD.MU)
As of 8:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
123,734.00
127,039.00
120,323.00
167,892.00
151,970.00
--
Investing Cash Flow
-161,680.00
90,906.00
-114,327.00
136,126.00
-119,263.00
--
Financing Cash Flow
-5,843.00
-148,723.00
-17,284.00
-302,591.00
12,214.00
--
End Cash Position
128,588.00
135,551.00
66,329.00
77,617.00
76,190.00
--
Income Tax Paid Supplemental Data
--
47,602.00
39,747.00
9,104.00
10,856.00
--
Capital Expenditure
-453.00
-139.00
-413.00
-469.00
-1,238.00
--
Repurchase of Capital Stock
--
-145,428.00
--
-295,985.00
-9,945.00
--
Free Cash Flow
123,281.00
126,900.00
119,910.00
167,423.00
150,732.00
--
12/31/2019 - 3/18/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1VT.F Viking Therapeutics, Inc.
60.78
+2.67%
IVA.PA Inventiva S.A.
2.6100
-0.76%
SGMT Sagimet Biosciences Inc.
5.60
+0.59%
GMAB Genmab A/S
22.51
-1.18%
REGN Regeneron Pharmaceuticals, Inc.
968.54
+0.00%
NOVO-B.CO Novo Nordisk A/S
800.00
-0.94%
VRTX Vertex Pharmaceuticals Incorporated
474.49
-0.75%
MRNA Moderna, Inc.
53.59
-0.40%